{
    "clinical_study": {
        "@rank": "25053", 
        "acronym": "ParisK", 
        "arm_group": {
            "arm_group_label": "18F-choline PET-CT imaging", 
            "arm_group_type": "Experimental", 
            "description": "Drug: 18F-choline, dosis 4 MBq/kg body-weight (maximum 360 MBq), administered intravenously as a single dose.\nProcedure: dynamic and static 18F-choline PET-CT imaging."
        }, 
        "brief_summary": {
            "textblock": "Accumulating data in the literature suggests that radiolabeled-choline (18F-choline) is a\n      sensitive molecular tracer for PET-CT imaging that is taken up in activated cells and, as\n      such, is able to identify active inflammatory sites."
        }, 
        "brief_title": "18F-choline PET-CT and MRI of Carotid Plaques", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Plaque, Atherosclerotic", 
        "condition_browse": {
            "mesh_term": [
                "Atherosclerosis", 
                "Plaque, Atherosclerotic"
            ]
        }, 
        "detailed_description": {
            "textblock": "Accumulation and subsequent activation of inflammatory cells in the atherosclerotic plaques\n      play an essential role in transforming a stable plaque into a vulnerable plaque at risk to\n      rupture. On this basis, the study aims to evaluate the diagnostic performance of 18F-choline\n      PET-CT in identifying ongoing inflammation within atherosclerotic plaques. We hypothesize\n      that 18F-choline is efficient in detecting intraplaque inflammation."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patient is a female or male of ay race age >18 years at the time of the\n             investigational product administration (no maximum age);\n\n          -  Informed consent by signing informed consent form regarding this study;\n\n          -  Patients known with carotid artery stenosis >50%, who are scheduled for carotid\n             endarterectomy.\n\n        Exclusion Criteria:\n\n          -  Dementia, pregnancy, nursing mothers;\n\n          -  Patients who do have a documented allergy for CT contrast media;\n\n          -  Patients with a renal clearance <45 ml/min/1.73m2 or <60 ml/min/1.73m2 in patients\n             with diabetes mellitus;\n\n          -  Serious neurological deficits at symptomatic side (hemi paralysis, complete aphasia);\n\n          -  Severe heart failure NYHA III-IV and severe pulmonary dysfunction dependent on oxygen\n             supply."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01899014", 
            "org_study_id": "NL43466.068.13", 
            "secondary_id": "2013-000456-17"
        }, 
        "intervention": {
            "arm_group_label": "18F-choline PET-CT imaging", 
            "description": "18F-choline PET-CT imaging", 
            "intervention_name": "18F-choline PET-CT imaging", 
            "intervention_type": "Drug", 
            "other_name": [
                "18F-fluormethylcholine", 
                "[F18] choline", 
                "[F18] fluormethylcholine"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": "Choline"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Atherosclerosis", 
            "18F-choline", 
            "PET-CT", 
            "MRI", 
            "Ultrasound"
        ], 
        "lastchanged_date": "August 20, 2013", 
        "link": [
            {
                "description": "CTMM project", 
                "url": "http://www.ctmm.nl/en"
            }, 
            {
                "description": "ParisK study", 
                "url": "http://www.ctmm.nl/en/projecten/hartvaat/parisk-1"
            }
        ], 
        "location": {
            "facility": {
                "address": {
                    "city": "Maastricht", 
                    "country": "Netherlands", 
                    "zip": "6229 HX"
                }, 
                "name": "University Hospital Maastricht"
            }, 
            "investigator": {
                "last_name": "S. A. Voo, MD, PhD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "1", 
        "official_title": "Plaque at Risk (ParisK): Molecular Imaging of Plaque Vulnerability Using 18F-choline PET-CT and MRI in Patients With Carotid Artery Atherosclerosis", 
        "overall_contact": {
            "email": "stefan.voo@mumc.nl", 
            "last_name": "S. A. Voo, MD, PhD", 
            "phone": "+31433877297"
        }, 
        "overall_official": {
            "affiliation": "Maastricht University Medical Center", 
            "last_name": "M. E. Kooi, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "To correlate the 18F-choline uptake in the atherosclerotic plaque with the degree of intraplaque inflammation, as assessed on histology.", 
            "safety_issue": "No", 
            "time_frame": "1 year"
        }, 
        "reference": [
            {
                "PMID": "18183393", 
                "citation": "Bucerius J, Schmaljohann J, B\u00f6hm I, Palmedo H, Guhlke S, Tiemann K, Schild HH, Biersack HJ, Manka C. Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans--first results. Eur J Nucl Med Mol Imaging. 2008 Apr;35(4):815-20. doi: 10.1007/s00259-007-0685-x. Epub 2008 Jan 6."
            }, 
            {
                "PMID": "19430785", 
                "citation": "Kato K, Schober O, Ikeda M, Sch\u00e4fers M, Ishigaki T, Kies P, Naganawa S, Stegger L. Evaluation and comparison of 11C-choline uptake and calcification in aortic and common carotid arterial walls with combined PET/CT. Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1622-8. doi: 10.1007/s00259-009-1152-7. Epub 2009 May 9."
            }, 
            {
                "PMID": "20532464", 
                "citation": "F\u00f6rster S, Rominger A, Saam T, Wolpers S, Nikolaou K, Cumming P, Reiser MF, Bartenstein P, Hacker M. 18F-fluoroethylcholine uptake in arterial vessel walls and cardiovascular risk factors: correlation in a PET-CT study. Nuklearmedizin. 2010;49(4):148-53. doi: 10.3413/nukmed-0299. Epub 2010 Jun 8."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01899014"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "To correlate the intra-plaque 18F-choline uptake on PET with other histologic plaque parameters besides inflammation.", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "To correlate the intra-plaque 18F-choline uptake on PET with atherosclerotic plaque parameters assessed on CT, MRI, and ultrasound.", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "To compare on PET the 18F-choline uptake in the symptomatic carotid plaque with the uptake in the asymptomatic contralateral carotid artery.", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }, 
            {
                "measure": "To evaluate a possible association between the degree of 18F-choline uptake on PET with patients' cardiovascular risk profile and medical history.", 
                "safety_issue": "No", 
                "time_frame": "1 year"
            }
        ], 
        "source": "Maastricht University Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Center for Translational Molecular Medicine", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Maastricht University Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}